SUMMIT ROCK ADVISORS, LP

PrivateCIK: 1540951
Location

NEW YORK, NY

πŸ“‹ What this filing means

SUMMIT ROCK ADVISORS, LP filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $128.1K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

5
Positions
$128.1K
Total AUM (reported)
1.62M
Total Shares

Allocation by class

TOTAL AUM$128.1K5 positions
ENERGY$78.1K61.0%
RUS 2000 VAL ETF$43.7K34.1%
TT WRLD ST ETF$5.3K4.1%
COM CL A$559.000.4%
COM$516.000.4%

Portfolio Concentration

Top 399.2%4–100.8%TOP 10100.0%0%100%
Top 3$127.1K99.2%
4–10$1.1K0.8%

Top 3 weight

99.2%

Top 10 weight

100.0%

Voting Authority Distribution

Total shares with voting rights: 1.62M

Sole

Full voting authority

1.62M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole5
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings5
Rows:

SELECT SECTOR SPDR TR

SOLE
ENERGY
Shares1.08M
TypeSH
Market value$78.1K
60.96%
Sole
1.08M
Shared
0.00
None
0.00

ISHARES TR

SOLE
RUS 2000 VAL ETF
Shares338.86K
TypeSH
Market value$43.7K
34.10%
Sole
338.86K
Shared
0.00
None
0.00

VANGUARD INTL EQUITY INDEX F

SOLE
TT WRLD ST ETF
Shares66.60K
TypeSH
Market value$5.3K
4.10%
Sole
66.60K
Shared
0.00
None
0.00

PLANET LABS PBC

SOLE
COM CL A
Shares102.88K
TypeSH
Market value$559.00
0.44%
Sole
102.88K
Shared
0.00
None
0.00

DAY ONE BIOPHARMACEUTICALS I

SOLE
COM
Shares25.75K
TypeSH
Market value$516.00
0.40%
Sole
25.75K
Shared
0.00
None
0.00
SUMMIT ROCK ADVISORS, LP 13F Holdings β€” 5 Positions | Finecho